Nicolan (Nicorandil)

Nicorandil, the active ingredient in Nicolan, is a potassium channel opener; nitrate vasodilator presented as an oral tablet for oral use. It is employed to relieve chest pain in patients with stable angina by improving coronary blood flow and reducing cardiac workload, and decreasing myocardial oxygen demand. The drug acts quickly and is taken regularly as part of a comprehensive anti‑anginal regimen.

GNH USA supplies Nicolan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with reliable logistics and quality assurance.

Nicorandil is indicated for the management of stable angina, an ischemic heart disease condition.

Stable angina: reduces frequency and severity of chest pain episodes by improving myocardial perfusion. Chronic stable angina: helps maintain exercise tolerance and quality of life.

Nicorandil may be associated with several adverse reactions, which are categorised by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: warmth and redness, usually short‑lived. - Dizziness or light‑headedness: related to blood pressure changes. - Nausea or dyspepsia: gastrointestinal discomfort. - Palpitations: awareness of heartbeat, generally benign. - Mild hypotension: drop in blood pressure without severe symptoms.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring medical attention. - Tachycardia or arrhythmia: rapid or irregular heart rhythm. - Myocardial infarction: rare but serious cardiac event. - Allergic reactions: rash, itching, or swelling. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Gastrointestinal ulceration or perforation: rare but potentially life‑threatening.

When prescribing Nicolan, clinicians should consider several safety measures.

Cardiovascular monitoring: assess blood pressure and heart rate before and during therapy. Severe hypotension: avoid use in patients with markedly low blood pressure. Concurrent nitrates: use with caution to prevent additive vasodilation. Hepatic impairment: dose adjustment may be required in severe liver disease. Pregnancy and lactation: safety not established; avoid unless clearly needed. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nicorandil can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other nitrates (e.g., glyceryl trinitrate): risk of profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe blood pressure fall. - Potent vasodilators (e.g., hydralazine): additive hypotensive effect.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, ARBs, beta‑blockers): monitor blood pressure. - Diuretics: may enhance volume depletion and hypotension. - Antiplatelet agents (aspirin, clopidogrel): watch for bleeding if ulceration occurs. - CYP450 modulators: although Nicorandil is not a major CYP substrate, monitor for unexpected changes in plasma levels.